For in vivo studies, we used Eca-109 cells in three groups: NC, HACE1, and HACE1+siTRIP12, and observed that TRIP12 silencing significantly exacerbated tumor growth on the basis of HACE1 overexpression (Figure 8A-8C). The gene discussed is TRIP12; the disease is neoplasm.